Institute for Myeloma & Bone Cancer Research

Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly... The post Targeted Oncology appeared first on Institute for Myeloma & Bone Cancer ...

https://imbcr.org/targeted-oncology/

Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11... The post American Society of Hematology appeared first on Institute for Myeloma & B...

https://imbcr.org/american-society-of-hematology/

Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential... The post MedPage Today appeared first on Institute for Myelom...

https://imbcr.org/medpage-today/

Multiple Myeloma regimens significantly less effective in real-world treatment settings In this study, researchers looked... The post HemOnc Today appeared first on Institute for Myeloma & Bon...

https://imbcr.org/hemonc-today-multiple-myeloma-regimens-significantly-less-effective-in-real-world-treatment-settings/

Healio Hematology & Oncology News: Interviewed Dr. Berenson on his perspective on Abstract 1 &... The post Healio Hematology & Oncology News appeared first on Institute for Myeloma & Bone Canc...

https://imbcr.org/healio-hematology-oncology-news/

Has built many patient programs and over 8 integrated software platforms to help blood cancer... The post HealthTree Foundation appeared first on Institute for Myeloma & Bone Cancer Research .

https://imbcr.org/healthtree-foundation/

| James Berenson, MD | ASH 2023 – video The post Outcomes of Triple Class Refractory Multiple Myeloma Patients appeared first on Institute for Myeloma & Bone Cancer Research .

https://imbcr.org/outcomes-of-triple-class-refractory-multiple-myeloma-patients/

| James Berenson, MD | ASH 2023 – video The post Medical Writing Bias in Myeloma Clinical Research appeared first on Institute for Myeloma & Bone Cancer Research .

https://imbcr.org/medical-writing-bias-in-myeloma-clinical-research/

| James Berenson, MD | ASH 2023 video The post Assessing Lenalidomide with Patients Progressing on JAK Inhibitors appeared first on Institute for Myeloma & Bone Cancer Research .

https://imbcr.org/assessing-lenalidomide-with-patients-progressing-on-jak-inhibitors/

 VJHemOnc: (The Video Journal of Hematological Oncology) is an open-access video journal dedicated to providing... The post VJHemOnc appeared first on Institute for Myeloma & Bone Cancer Rese...

https://imbcr.org/vjhemonc/